ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody<img src="http://feeds.foxbusiness.com/~r/foxbusiness/latest/~4/314364094" height="1" width="1"/><img src="http://feeds.foxnews.com/~r/foxnews/business/~4/314373009" height="1" width="1"/>
http://feeds.foxnews.com/~r/foxnews/business/~3/314373009/-1490189764